?
Johnson Kimberly H
Director
Eli Lilly and Company
US, Indianapolis [HQ]
CIK
1658089
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
3,032,146
Price per Share :
$725.72
Equivalence :
$2,200,488,995.12
Transaction History
-
A3,032,146 Shares After TransactionValue : $2,362,041,734.00$9,666,611.00Transaction Date : 12/16/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,614 Shares After TransactionValue : $1,993,593.24$9,914.58Transaction Date : 03/18/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,654 Shares After TransactionValue : $2,348,816.54$9,735.11Transaction Date : 06/17/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,712,818 Shares After TransactionValue : $1,972,761,249.60$9,666,669.60Transaction Date : 11/18/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A3,015,348 Shares After TransactionValue : $2,192,761,065.60$21,999,981.60Transaction Date : 11/18/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.